NYSE:DHRLife Sciences
Is Danaher’s (DHR) Euro Debt for Masimo a Smart Balance-Sheet Bet or Added Complexity?
Earlier this week, Danaher Corporation priced a euro-denominated senior notes offering totaling about €2.98 billion across floating and fixed-rate tranches maturing between 2028 and 2038, primarily to help fund its pending acquisition of Masimo Corporation and for potential general corporate uses.
This financing move ties Danaher’s balance sheet directly to its Masimo ambitions, aligning long-dated euro debt with an acquisition expected to reshape its medical technology footprint.
We’ll now...